The expression of HNRNPA2B1 correlates significantly with TMB, MSI, tumor stemness, and chemotherapeutic response, and it is implicated in the modulation of novel immunotherapies and the infiltration of a diverse array of immune cells. This evidence concerns the gene HNRNPA2B1 and neoplasm.